We are live on
!
Find out more
SCA
Sage Capital Advisors Portfolio holdings
AUM
$482M
1-Year Est. Return
34.73%
This Fund
S&P 500
This Quarter
Est. Return
-0.51%
1 Year Est. Return
+34.73%
3 Year Est. Return
+89.43%
5 Year Est. Return
+100.2%
10 Year Est. Return
–
AUM
$143M
AUM Growth
+$1.65M
(+1.2%)
Cap. Flow
+$3.09M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
95
New
11
Increased
41
Reduced
16
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.46M |
| 2 |
AbbVie
ABBV
|
+$1.76M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$871K |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$635K |
| 5 |
Micron Technology
MU
|
+$549K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$3.04M |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.53M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$652K |
| 4 |
Global X SuperDividend ETF
SDIV
|
+$565K |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$497K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.83% |
| 2 | Financials | 14.2% |
| 3 | Consumer Staples | 12.51% |
| 4 | Technology | 10.94% |
| 5 | Healthcare | 10.38% |
Similar funds
IG
SDWIA
BAG
EFA
MAM
NQWM
BAM
BWA
Sage Capital Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Sage Capital Advisors held 95 positions worth $143M, up 1.2% from $141M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Sage Capital Advisors's Q2 2018 filing shows 11 new, 41 increased, 16 reduced and 8 closed positions. Its largest new stake was Bristol-Myers Squibb: 64,020 shares worth $3.54M. The largest sale was United Therapeutics, an estimated $3.04M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Staples.
- Sage Capital Advisors's largest Q2 2018 buy was Bristol-Myers Squibb: 64,020 shares worth $3.54M.
- Sage Capital Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $871K increase.
- Sage Capital Advisors's biggest Q2 2018 reduction was Apple, cutting an estimated $169K.
- Sage Capital Advisors fully exited United Therapeutics in Q2 2018, selling an estimated $3.04M.
- Sage Capital Advisors's ten largest holdings make up 40% of its $143M portfolio in Q2 2018.
- Sage Capital Advisors opened 11 new positions and closed 8 in Q2 2018.
- Sage Capital Advisors's portfolio value rose 1.2% quarter-over-quarter to $143M.
Based on Sage Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.